Mostly harmless? Clinical practice guidelines need further consideration of psychotherapy adverse effects

Stephen Allison*, Jeffrey C.L. Looi, Steve Kisely, Tarun Bastiampillai

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)

Abstract

The Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines on mood disorders recommend psychotherapy as foundational care for patients with acute depression with minimal discussion of any potential adverse effects. Randomised controlled trial evidence on psychotherapy adverse effects is limited. This is problematic because clinicians must balance the benefits of treatment against the harms, and clinical decisions become skewed without data on adverse effects. We suggest that clinical practice guidelines should be more guarded about recommending psychotherapy and add consensus statements on adverse effects for informed consent and clinical decision-making.

Original languageEnglish
Pages (from-to)25-27
Number of pages3
JournalAustralasian Psychiatry
Volume33
Issue number1
DOIs
Publication statusPublished - Feb 2025

Fingerprint

Dive into the research topics of 'Mostly harmless? Clinical practice guidelines need further consideration of psychotherapy adverse effects'. Together they form a unique fingerprint.

Cite this